BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 1 hour ago Valaris Limited Drops 6.7% in Broad Selloff 2 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 2 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 2 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 3 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 3 hours ago Celanese Corporation Shares Dropping 5.5% 3 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 3 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 3 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 3 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 1 hour ago Valaris Limited Drops 6.7% in Broad Selloff 2 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 2 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 2 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 3 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 3 hours ago Celanese Corporation Shares Dropping 5.5% 3 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 3 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 3 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 3 hours ago
ADVERTISEMENT
Market News

Diebold (NYSE: DBD): Q4 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected. — Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue. — Sales from Eurasia Banking […]

February 11, 2020 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected. — Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue. — Sales from Eurasia Banking […]

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected.

— Total net sales declined by 11% to $1.15 billion versus $1.16 billion expected. The results were impacted by divestitures and other deliberate actions to improve the quality of revenue.

Earnings Update by AlphaStreet

— Sales from Eurasia Banking dropped by 13% and that from the Americas Banking declined by 3%. Total retail sales fell by 18%.

— Looking ahead into the full year 2020, the company expects its total revenue in the range of $4.2-4.3 billion. The consensus estimates revenue of $4.27 billion.

— Adjusted EBITDA is expected to be in the range of $430-470 million and net cash provided by operating activities is predicted to be in the $170-200 million range for the full year.

— Capital expenditures are anticipated to be about $70 million while free cash flow is projected to be $100-130 million for the full year 2020.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT